The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations.
Global Genome Editing market is projected to reach US$ 6739.8 million in 2029, increasing from US$ 3513 million in 2022, with the CAGR of 9.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Genome Editing market research.
The increasing application of genome engineering in treating chronic ailments and therapeutics will be one of the key factors fueling the growth of genome editing market during the next few years. With the continuous prevalence of infectious and chronic diseases such as hepatitis, tuberculosis, malaria, HIV/AIDS, and others, the application of genome editing in treating these ailments has increased considerably in the recent years. According to CDC, there were about 1.8 million new cases of HIV reported in 2016. Such a rapidly increasing number of HIV cases have led to the researchers to work on new gene-based therapies for reducing morbidity and mortality of HIV-infected patients. Consequently, the rise in prevalence of such ailments will impact the demand for novel therapies equipping several genome editing tools in the forthcoming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Genome Editing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company(Partial List)
- Genscript
- Horizon Discovery Group
- Lonza
- Merck KGaA
- Sangamo Therapeutics
- Thermo Fisher Scientific
Segment by Type
- CRISPR
- TALEN
- ZFN
Segment by Application
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
The Genome Editing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genome Editing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CRISPR
1.2.3 TALEN
1.2.4 ZFN
1.3 Market by Application
1.3.1 Global Genome Editing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cell Line Engineering
1.3.3 Animal Genetic Engineering
1.3.4 Plant Genetic Engineering
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome Editing Market Perspective (2018-2029)
2.2 Genome Editing Growth Trends by Region
2.2.1 Global Genome Editing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genome Editing Historic Market Size by Region (2018-2023)
2.2.3 Genome Editing Forecasted Market Size by Region (2024-2029)
2.3 Genome Editing Market Dynamics
2.3.1 Genome Editing Industry Trends
2.3.2 Genome Editing Market Drivers
2.3.3 Genome Editing Market Challenges
2.3.4 Genome Editing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome Editing Players by Revenue
3.1.1 Global Top Genome Editing Players by Revenue (2018-2023)
3.1.2 Global Genome Editing Revenue Market Share by Players (2018-2023)
3.2 Global Genome Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genome Editing Revenue
3.4 Global Genome Editing Market Concentration Ratio
3.4.1 Global Genome Editing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Editing Revenue in 2022
3.5 Genome Editing Key Players Head office and Area Served
3.6 Key Players Genome Editing Product Solution and Service
3.7 Date of Enter into Genome Editing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genome Editing Breakdown Data by Type
4.1 Global Genome Editing Historic Market Size by Type (2018-2023)
4.2 Global Genome Editing Forecasted Market Size by Type (2024-2029)
5 Genome Editing Breakdown Data by Application
5.1 Global Genome Editing Historic Market Size by Application (2018-2023)
5.2 Global Genome Editing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genome Editing Market Size (2018-2029)
6.2 North America Genome Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genome Editing Market Size by Country (2018-2023)
6.4 North America Genome Editing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome Editing Market Size (2018-2029)
7.2 Europe Genome Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genome Editing Market Size by Country (2018-2023)
7.4 Europe Genome Editing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genome Editing Market Size (2018-2029)
8.2 Asia-Pacific Genome Editing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genome Editing Market Size by Region (2018-2023)
8.4 Asia-Pacific Genome Editing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genome Editing Market Size (2018-2029)
9.2 Latin America Genome Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genome Editing Market Size by Country (2018-2023)
9.4 Latin America Genome Editing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome Editing Market Size (2018-2029)
10.2 Middle East & Africa Genome Editing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genome Editing Market Size by Country (2018-2023)
10.4 Middle East & Africa Genome Editing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genscript
11.1.1 Genscript Company Detail
11.1.2 Genscript Business Overview
11.1.3 Genscript Genome Editing Introduction
11.1.4 Genscript Revenue in Genome Editing Business (2018-2023)
11.1.5 Genscript Recent Development
11.2 Horizon Discovery Group
11.2.1 Horizon Discovery Group Company Detail
11.2.2 Horizon Discovery Group Business Overview
11.2.3 Horizon Discovery Group Genome Editing Introduction
11.2.4 Horizon Discovery Group Revenue in Genome Editing Business (2018-2023)
11.2.5 Horizon Discovery Group Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Genome Editing Introduction
11.3.4 Lonza Revenue in Genome Editing Business (2018-2023)
11.3.5 Lonza Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Detail
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Genome Editing Introduction
11.4.4 Merck KGaA Revenue in Genome Editing Business (2018-2023)
11.4.5 Merck KGaA Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Detail
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics Genome Editing Introduction
11.5.4 Sangamo Therapeutics Revenue in Genome Editing Business (2018-2023)
11.5.5 Sangamo Therapeutics Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Genome Editing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Genome Editing Business (2018-2023)
11.6.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
